Sponsor Pipeline

chenxu Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
0
Recruiting
1
Disease Areas
Active Trials by Phase
Phase 2
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07474064 Probiotics Combined With Targeted Therapy Plus Immunotherapy in Bladder-Preserving… Muscle Invasive Bladder Cancer (MIBC) Not Yet Recruiting
Disease Areas
Bladder Cancer (1)
Get alerts when chenxu's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free